LAS VEGAS, Jan. 28, 2020 /PRNewswire/ -- JanOne Inc.
(NASDAQ:JAN), a company focused on finding treatments for
conditions that cause severe pain and bringing to market drugs and
therapies with nonaddictive pain-relieving properties, announced
the addition of Amol Soin, MD as the
company's chief medical officer. Dr. Soin has been recognized
multiple times as one of America's Top Doctors and is the recipient
of the Patient's Choice Award, an honor given only to the top 1% of
physicians in the country.
Considered one of the nation's top pain experts, Dr. Soin brings
significant expertise for treating neuropathic and chronic pain and
extensive research experience for non-opioid, nonaddictive pain
solutions to the JanOne management team. In his role as chief
medical officer, Dr. Soin will guide JanOne's drug development
activities, manage clinical research, set patient safety standards,
and ensure regulatory compliance. In addition, Dr. Soin will play
an integral role in establishing partnerships and drug candidate
selection as the company expands its pipeline.
"I have worked with Dr. Soin for over 10 years," commented Dr.
Tony Giordano, JanOne's chief
scientific officer. "He played an instrumental role in our research
for TV1001SR, our lead candidate for peripheral artery disease
(PAD), and his wealth of knowledge and expertise in various areas
of pain and pain management are unmatched. I am excited to once
again work alongside him to advance our clinical research and to
explore new options for treating pain and diseases, such as PAD,
that can cause severe pain."
Dr. Soin received his undergraduate degree from University of Akron, his MBA from University of Tennessee, his MD from Northeastern
Ohio Universities College of Medicine, his master's in science from
Brown University and also has studied
at Dartmouth College. He is board
certified in anesthesiology and pain medicine and a fellow of
interventional pain management at the World Institute of Pain, and
he served as a pain management fellow at the Cleveland Clinic, the
oldest and largest academic pain management department in
the United States. The founder and
chairman of the Ohio Pain Clinic, Dr. Soin has also held several
prestigious positions including President of the Ohio Society of
Interventional Pain Physicians, president of the American Society
of Interventional Pain Physicians Foundation, president of the
Society of Interventional Pain Management Surgery Centers and
president – elect of TriState Pain Society. He was appointed by
Governor Kasich to the Ohio Medical Board in 2012 to two 5 year
terms and has served as the Ohio Medical Board's president where he
was instrumental in passing statewide rules and guidelines to help
the opioid crisis.
"I could not be more pleased to join the JanOne team. The focus
on diseases that cause severe pain with the underlying potential to
impact opioid abuse at the prescription pad is directly aligned
with my work over the past 18 years," commented Dr. Soin. "The team
at JanOne has demonstrated their commitment to help millions of
patients who suffer from pain causing diseases such as PAD and to
make an impact on society by reducing the need for opioid
prescriptions. It is an honor to be a part of the leadership
team."
Dr. Soin is a nationally recognized speaker and author of the
book "Curing America." He has also authored a range of
research papers, publications, and abstracts and served as a
primary investigator for various clinical research initiatives.
Presently, Dr. Soin serves as the State
of Ohio's Medicare carrier advisory committee's Pain
Management Representative and serves on the prescription drug abuse
committee and legislative task force for the Ohio State Medical
Association. Ohio currently has
second highest rate of prescription opioid overdose
deaths1.
Tony Isaac, CEO of JanOne, said,
"Dr. Soin has an impeccable reputation as a medical expert and
researcher in pain and pain management. Combined with his
dedication to reduce opioid abuse at the prescription pad, we are
confident he will make a significant contribution to the success of
JanOne."
In addition to serving as chief medical officer at JanOne, Dr.
Soin will continue as an active practicing physician who
specializes in pain associated with peripheral artery disease,
diabetic neuropathy, and poor wound healing. Dr. Soin will operate
from his current office in Centerville,
Ohio.
About JanOne
JanOne is a unique NASDAQ-listed company that is focused on
bringing medications to market to treat disease that cause severe
pain in an effort to reduce the need for prescriptions opioids
often used to treat disease associated pain. The company is also
exploring solutions for non-addictive pain medications. The lead
candidate is for treating peripheral artery disease (PAD), a
condition that affects over 8.5 million Americans, with plans
currently underway for phase 2b
trials. JanOne is currently dedicated to funding resources toward
innovation, technology, and education for PAD and neuropathic pain.
The company continues to operate its legacy businesses as
subsidiaries, Appliance Recycling Centers of America and GeoTraq
under their current brand names. Appliance Recycling Centers of
America provides turnkey recycling and replacement services for
utilities and other sponsors of energy efficiency programs.
JanOne's subsidiary GeoTraq engages in the development, design and
sale of Mobile IoT modules. Please visit www.janone.com for
additional information.
Media contact:
Mark Rosenberg
mark@trueparallel.com
919-412-7378
1 National Institute of Health, Ohio Opioid Summary,
revised March 2019
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amol-soin-md-one-of-the-nations-leading-pain-experts-named-as-janones-chief-medical-officer-300994259.html
SOURCE JanOne